Figure 2A: Cumulative incidence of any subsequent malignant neoplasms in aBMT survivors by IMiD exposure
Figure 2B: Cumulative incidence of Solid Tumors in aBMT survivors by IMiD exposure
Figure 2C: Cumulative incidence of Melanoma in aBMT survivors by IMiD exposure
Figure 2D: Cumulative incidence of SCC in aBMT survivors by IMiD exposure
Abbreviations: aBMT: Autologous blood or marrow transplantation, SCC: squamous cell carcinoma, IMiD: Immunomodulatory drugs